GlassScriptPhysician profile
Morgan Donnell
NPI 1710705298
$708.62
in general payments reported to CMS, 2019-2025
14 companies · $709 in 2025
The $709 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.68 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $165.93 | 2025 | Dupixent |
| Baxter Healthcare | $106.96 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $90.68 | 2025 | Tezspire, Fasenra, Airsupra |
| Grifols USA, LLC | $68.96 | 2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.31 | 2025 | Ofev |
| United Therapeutics Corporation | $33.00 | 2025 | Tyvaso |
| Viatris Specialty LLC | $32.19 | 2025 | Yupelri |
| Insmed, INC. | $28.04 | 2025 | Arikayce |
| La Jolla Pharmaceutical Company | $25.86 | 2025 | Giapreza |
| Actelion Pharmaceuticals US, INC. | $25.71 | 2025 | Opsumit, Uptravi |
| Genzyme Corporation | $22.23 | 2025 | |
| Resmed Corp | $20.41 | 2025 | |
| Harmony Biosciences LLC | $20.36 | 2025 | |
| Amgen INC. | $17.98 | 2025 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Donnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.